TKG Therapeutics

Tokyo, Japan

TKG Therapeutics is a pharmaceutical company that focuses on developing nucleic acid drugs using new-age medical technology.

$1.0M raised

Jan 2024

Seed

Biotechnology Life Science Medical Pharmaceutical

Top Investors

UntroD Capital NEDO Mitsubishi Gas Chemical

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about TKG Therapeutics

How much funding has TKG Therapeutics raised?

TKG Therapeutics has raised $1.0M in total funding. The most recent round was Seed. The last funding was announced in January 2024.

Who are TKG Therapeutics's investors?

TKG Therapeutics's investors include UntroD Capital, NEDO, Mitsubishi Gas Chemical.

Where is TKG Therapeutics headquartered?

TKG Therapeutics is headquartered in Tokyo, Japan.

What does TKG Therapeutics do?

TKG Therapeutics is a pharmaceutical company that focuses on developing nucleic acid drugs using new-age medical technology.

What stage is TKG Therapeutics at?

TKG Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 31, 2024.

MLA

"TKG Therapeutics — Funding & Investors." VCBacked, January 31, 2024, https://www.vcbacked.co/company/tkg-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2024). TKG Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/tkg-therapeutics

Wikipedia (cite web)

{{cite web |title=TKG Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tkg-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 31, 2024.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K